CHRISTOPHER M. STARR - 02 Dec 2025 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Role
Director
Signature
/s/ Quan Vu, Attorney-in-fact
Issuer symbol
MNPR
Transactions as of
02 Dec 2025
Transactions value $
$0
Form type
4
Filing time
08 Dec 2025, 16:50:08 UTC
Previous filing
16 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
STARR CHRISTOPHER M Director 1000 SKOKIE BLVD SUITE 350, WILMETTE /s/ Quan Vu, Attorney-in-fact 08 Dec 2025 0001235470

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNPR Stock Options Award $0 +2.92K $0.00 2.92K 02 Dec 2025 Common Stock 2.92K $75.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options vest 25% quarterly on March 31, 2026, June 30, 2026, September 30, 2026 and December 31, 2026.